This 100 Rs. Tablet Can Cure Cancer - TATA Institue Discovers
This novel pill is thought to prevent cancer from returning and minimise side effects from treatments like radiation and chemotherapy by 50%. It is the product of 10 years of study and testing. The studies were carried out on mice, a mammal that is closely related to humans genetically.
The study team's leading cancer surgeon at Tata Memorial Hospital, Dr. Rajendra Badve, described how the finding was made.
These pills produce oxygen radicals in the stomach upon oral administration, which swiftly reach the circulation. This procedure stops cancer cells from spreading, a process known as metastases, and stops the release of chromatin particles free of cells into the bloodstream.
Additionally, according to the researchers, R+Cu pills lessen the toxicity that comes with treatment.
It is expected that the pill will work against mdata-alignancies of the mouth, lungs, and pancreas.
At now, the physicians are anticipating the endorsement from the Food Safety and Standards Authority of india (FSSAI). The tablet is anticipated to hit stores in june or July after approval.
According to Dr. Badve, if the pill is authorised, its price will be significantly lower. He stated that "compared to the lakhs and crores spent on the development, the tablet could be less than Rs 100."
It is anticipated that human trials would take a minimum of five years to conclude. "There were difficulties with the study, and many people thought it was a time and money waste. However, everyone is joyful and enthusiastic today. It is rather successful," he declared.